Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma

Radiotherapy and Oncology

Volumn 101, Issue 1, 2011, Pages 165-170

  Nijkamp, Monique M ^a   Hoogsteen, Ilse J ^a   Span, Paul N ^a   Takes, Robert P ^a   Lok, Jasper ^a   Rijken, Paul F ^a   Van Der Kogel, Albert J ^a   Bussink, Johan ^a   Kaanders, Johannes H A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Head and neck cancer; Hypoxia; pAKT; pEGFR; PI3 K AKT pathway

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER RECURRENCE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOSPHORYLATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 80655144396     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.06.022     Document Type: Article

References (43)

1. K. Dittmann, C. Mayer, R. Kehlbach, M.C. Rothmund, and H. Peter Rodemann Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport Radiother Oncol 92 2009 379 382
2. R.N. Jorissen, F. Walker, N. Pouliot, T.P. Garrett, C.W. Ward, and A.W. Burgess Epidermal growth factor receptor: mechanisms of activation and signalling Exp Cell Res 284 2003 31 53 (Pubitemid 36331965)
3. G. Carpenter, and S. Cohen Epidermal growth factor Annu Rev Biochem 48 1979 193 216 (Pubitemid 10191090)
4. T.F. Franke, D.R. Kaplan, L.C. Cantley, and A. Toker Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate Science 275 1997 665 668 (Pubitemid 27061333)
5. P. Liu, H. Cheng, T.M. Roberts, and J.J. Zhao Targeting the phosphoinositide 3-kinase pathway in cancer Nat Rev Drug Discov 8 2009 627 644
6. S. Kalyankrishna, and J.R. Grandis Epidermal growth factor receptor biology in head and neck cancer J Clin Oncol 24 2006 2666 2672 (Pubitemid 46622088)
7. R.E. Meyn, A. Munshi, J.V. Haymach, L. Milas, and K.K. Ang Receptor signaling as a regulatory mechanism of DNA repair Radiother Oncol 92 2009 316 322
8. U. Florczak, M. Toulany, R. Kehlbach, and H. Peter Rodemann 2-Methoxyestradiol-induced radiosensitization is independent of SOD but depends on inhibition of Akt and DNA-PKcs activities Radiother Oncol 92 2009 334 338
9. M. Toulany, R. Kehlbach, H.P. Rodemann, and H. Mozdarani Radiocontrast media affect radiation-induced DNA damage repair in vitro and in vivo by affecting Akt signalling Radiother Oncol 94 2010 110 116
10. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501 (Pubitemid 37328931)
11. K.K. Ang, B.A. Berkey, and X. Tu Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356 (Pubitemid 36025259)
12. K. Laimer, G. Spizzo, and G. Gastl High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis Oral Oncol 43 2007 193 198 (Pubitemid 46176708)
13. M. Maurizi, G. Almadori, and G. Ferrandina Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma Br J Cancer 74 1996 1253 1257 (Pubitemid 26360115)
14. Q.H. Wen, T. Miwa, T. Yoshizaki, I. Nagayama, M. Furukawa, and H. Nishijima Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy Laryngoscope 106 1996 884 888 (Pubitemid 26242129)
15. J. Rubin Grandis, M.F. Melhem, and W.E. Gooding Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival J Natl Cancer Inst 90 1998 824 832 (Pubitemid 28280548)
16. A.K. Gupta, W.G. McKenna, and C.N. Weber Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction Clin Cancer Res 8 2002 885 892 (Pubitemid 34742122)
17. Z. Yu, P.M. Weinberger, and C. Sasaki Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer Cancer Epidemiol Biomarkers Prev 16 2007 553 558 (Pubitemid 46548660)
18. J. Bussink, A.J. van der Kogel, and J.H. Kaanders Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer Lancet Oncol 9 2008 288 296 (Pubitemid 351722948)
19. J. Bussink, J.H. Kaanders, and A.J. van der Kogel Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy Radiother Oncol 82 2007 10 17 (Pubitemid 46097129)
20. E. Massarelli, D.D. Liu, and J.J. Lee Akt activation correlates with adverse outcome in tongue cancer Cancer 104 2005 2430 2436 (Pubitemid 41691564)
21. J. Lim, J.H. Kim, and J.Y. Paeng Prognostic value of activated Akt expression in oral squamous cell carcinoma J Clin Pathol 58 2005 1199 1205 (Pubitemid 41566467)
22. C. Blanco-Aparicio, O. Renner, J.F. Leal, and A. Carnero PTEN, more than the AKT pathway Carcinogenesis 28 2007 1379 1386 (Pubitemid 47243536)
23. Y. Hashimoto, A. Oga, and S. Kawauchi Amplification of 3q26 approximately qter correlates with tumor progression in head and neck squamous cell carcinomas Cancer Genet Cytogenet 129 2001 52 56 (Pubitemid 32743380)
24. W. Qiu, F. Schonleben, and X. Li PIK3CA mutations in head and neck squamous cell carcinoma Clin Cancer Res 12 2006 1441 1446
25. P.F. Rijken, H.J. Bernsen, J.P. Peters, R.J. Hodgkiss, J.A. Raleigh, and A.J. van der Kogel Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis Int J Radiat Oncol Biol Phys 48 2000 571 582
26. H.P. Rodemann Molecular radiation biology: perspectives for radiation oncology Radiother Oncol 92 2009 293 298
27. K.K. Ang, N.H. Andratschke, and L. Milas Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy Int J Radiat Oncol Biol Phys 58 2004 959 965 (Pubitemid 38221156)
28. H. Endoh, Y. Ishibashi, and E. Yamaki Immunohistochemical analysis of phosphorylated epidermal growth factor receptor might provide a surrogate marker of EGFR mutation Lung Cancer 63 2009 241 246
29. Y. Nieto, F. Nawaz, R.B. Jones, E.J. Shpall, and S. Nawaz Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer J Clin Oncol 25 2007 4405 4413 (Pubitemid 350013846)
30. W.K. Yip, V.C. Leong, M.A. Abdullah, S. Yusoff, and H.F. Seow Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma Oncol Rep 19 2008 319 328 (Pubitemid 351176090)
31. W.M. Ongkeko, X. Altuna, R.A. Weisman, and J. Wang-Rodriguez Expression of protein tyrosine kinases in head and neck squamous cell carcinomas Am J Clin Pathol 124 2005 71 76 (Pubitemid 40944376)
32. A. Shah, W.A. Swain, and D. Richardson Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer Clin Cancer Res 11 2005 2930 2936 (Pubitemid 40525195)
33. J.A. Engelman, K. Zejnullahu, and T. Mitsudomi MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling Science 316 2007 1039 1043 (Pubitemid 46799492)
34. J. Bernier, S.M. Bentzen, and J.B. Vermorken Molecular therapy in head and neck oncology Nat Rev Clin Oncol 6 2009 266 277
35. A. Franovic, L. Gunaratnam, K. Smith, I. Robert, D. Patten, and S. Lee Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer Proc Natl Acad Sci U S A 104 2007 13092 13097 (Pubitemid 351737598)
36. D.E. Swinson, and K.J. O'Byrne Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer Clin Lung Cancer 7 2006 250 256 (Pubitemid 43280027)
37. P. Vaupel, and A. Mayer Hypoxia in cancer: significance and impact on clinical outcome Cancer Metastasis Rev 26 2007 225 239 (Pubitemid 47101660)
38. M. Krause, G. Ostermann, and C. Petersen Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation Radiother Oncol 76 2005 162 167 (Pubitemid 41725443)
39. A. Santiago, W. Eicheler, and J. Bussink Effect of cetuximab and fractionated irradiation on tumour micro-environment Radiother Oncol 97 2010 322 329
40. S.Y. Nam, H.S. Lee, and G.A. Jung Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis APMIS 111 2003 1105 1113 (Pubitemid 38091249)
41. J.N. Hutchinson, J. Jin, R.D. Cardiff, J.R. Woodgett, and W.J. Muller Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion Cancer Res 64 2004 3171 3178 (Pubitemid 38581419)
42. H.Y. Irie, R.V. Pearline, and D. Grueneberg Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition J Cell Biol 171 2005 1023 1034 (Pubitemid 41815834)
43. J.H. Kaanders, J. Bussink, and A.J. van der Kogel ARCON: a novel biology-based approach in radiotherapy Lancet Oncol 3 2002 728 737 (Pubitemid 35446742)